Heterogeneous expression of claudin-4 in human colorectal cancer: Decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis

Pathobiology

Volumn 74, Issue 1, 2007, Pages 32-41

  Ueda, Junya ^a   Semba, Shuho ^a   Chiba, Hideki ^b   Sawada, Norimasa ^b   Seo, Yasushi ^a   Kasuga, Masato ^a   Yokozaki, Hiroshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Claudin 4; Colorectal cancer; Invasion; Metastasis

Indexed keywords

CLAUDIN 4; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL MOTILITY; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR MEMBRANE; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BLOTTING, WESTERN; CELL MOVEMENT; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RNA, SMALL INTERFERING;

EID: 34248561456     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101049     Document Type: Article

References (56)

1. Fidler IJ: Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978;38:2651-2660.
2. Michelson S, Leith JT: Host response in tumor growth and progression. Invasion Metastasis 1996;16:235-246.
3. Kemperman H, Driessens M, La Riviere G, Meijne AM, Roos E: The role of integrins and integrin activation in liver metastasis. Invasion Metastasis 1994;14:98-108.
4. Weiss L, Ward PM. Cell detachment and metastasis: Cancer Metastasis Rev 1983;2:111-127.
5. Hazan RB, Qiao R, Keren R, Badano I, Suyama K: Cadherin switch in tumor progression. Ann NY Acad Sci 2004;1014:155-163.
6. Christofori G: New signals from the invasive front. Nature 2006;441:444-450.
7. Behrens J, Frixen U, Schipper J, Weidner M, Birchmeier W: Cell adhesion in invasion and metastasis. Semin Cell Biol 1992;3:169-178.
8. Hannigan G, Troussard AA, Dedhar S: Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 2005;5:51-63.
9. Woodhouse EC, Chuaqui RF, Liotta LA: General mechanisms of metastasis. Cancer 1997;80:1529-1537.
10. Martin TA, Mansel RE, Jiang WG: Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells. J Cell Physiol 2002;192:268-275.
11. Tsukita S, Furuse M: Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000;149:13-16.
12. Morita K, Furuse M, Fujimoto K, Tukita S: Claudin multigene family encoding fourtransmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 1999;96:511-516.
13. Chen Y, Lu Q, Schneeberger EE, Goodenough DA: Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 2000;11:849-862.
14. Anderson JM: Molecular structure of tight junctions and their role in epithelial transport. News Physiol Sci 2001;16:126-130.
15. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S: Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999;147:1351-1363.
16. Tsukita S, Furuse M, Itoho M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2:285-293.
17. Mitic LL, Anderson JM: Molecular architecture of tight junctions. Annu Rev Physiol 1998;60:121-142.
18. Balda MS, Matter K: The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 2000;19:2024-2033.
19. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM: The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998;273:29745-29753.
20. Rahner C, Mitic LL, Anderson JM: Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001;120:411-422.
21. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N: Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 1997;136:1239-1247.
22. Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alo PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ: Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 2003;9:2567-2575.
23. Long H, Crean CD, Lee WH, Cummings OW, Gabig TG: Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001;61:7878-7881.
24. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003;22:2021-2033.
25. Nichols LS, Ashfaq R, Iacobuzio-Donahue CA: Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol 2004;121:226-230.
26. Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 2005;18:511-518.
27. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, Leder G, Iwamura T, Adler G, Gress TM: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003;63:6265-6271.
28. Hewitt KJ, Agarwal R, Morin PJ: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006;6:186.
29. Agarwal R, D'Souza T, Morin PJ: Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 2005;65:7378-7385.
30. Japanese Society for Cancer of Colon and Rectum: General Rules for Clinical Pathological Studies on Cancer of the Colon, Rectum and Anus, ed 6. Tokyo, Kanehara, 1998.
31. Sobin LH, Wittekind CH: UICC TNM Classification of Malignant Tumors, ed 5. New York, Wiley, 1997.
32. Miskad UA, Semba S, Kato H, Yokozaki H: Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 2004;71:176-184.
33. Folz RJ, Nepluev I: Poly(A) cDNA-specific (PACS) RT-PCR: a quantitative method for the measurement of any poly(A)-containing mRNA not affected by contaminating genomic DNA. Biotechniques 2000;29:762-768.
34. Mima S, Tsutsumi S, Ushijima H, Takeda M, Fukuda I, Yokomizo K, Suzuki K, Sano K, Nakanishi T, Tomisato W, Tsuchiya T, Mizushima T: Induction of claudin-4 by nonsteroidal anti-inflammatory drugs and its contribution to their chemopreventive effect. Cancer Res 2005;65:1868-1876.
35. Zhu Y, Brannstrom M, Janson PO, Sundfeldt K: Differences in expression patterns of the tight junction proteins, claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours. Int J Cancer 2006;118:1884-1891.
36. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S: Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 2004;112:14-25.
37. Hoevel T, Macek R, Swisshelm K, Kubbies M: Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer 2004;108:374-383.
38. Aung PP, Mitani Y, Sanada Y, Nakayama H, Matsusaki K, Yasui W: Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch 2006;448:428-434.
39. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W: Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 2006;208:633-642.
40. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005;115:1765-1776.
41. Medici D, Hay ED, Goodenogh DA: Cooperation between snail and LEF-1 transcription factors is essential for TGF-β1-induced epithelial- mesenchymal transition. Mol Biol Cell 2006;17:1871-1879.
42. Usami Y, Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N, Komori T, Ito A, Yokozaki H: Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 2006;37:569-577.
43. Polette M, Gilles C, Nawrocki-Raby B, Lohi J, Hunziker W, Foidart JM, Birembaut P: Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res 2005;65:7691-7698.
44. Mullin JM: Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis. J Exp Zool 1997;279:484-489.
45. Boireau S, Buchert M, Samuel MS, Pannequin J, Ryan JL, Choquet A, Chapuis H, Rebillard X, Avances C, Ernst M, Joubert D, Mottet N, Hollande F: DNA-methylationdependent alterations of claudin-4 expression in human bladder carcinoma. Carcinogenesis, E-pub ahead of print.
46. Honda H, Pazin MJ, Ji H, Wernyj RP, Morin PJ: Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem 2006;281:21433-21444.
47. Carrozzine F, Soulie P, Huber D, Mensi N, Orci L, Cano A, Feraille E, Montesano R: Inducible expression of Snail selectively increases paracellular ion permeability and differentially modulates tight junction proteins. Am J Physiol Cell Physiol 2005;89:C1002-C1014.
48. Howe KL, Readon C, Wang A, Nazli A, McKay DM: Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157: H7-induced increased permeability. Am J Pathol 2005;167:1587-1597.
49. Zondag GC, Evers EE, ten Klooster JP, Janssen L, van der Kammen RA, Collard JG: Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J Cell Biol 2000;149:775-782.
50. Jo M, Thomas KS, Somlyo AV, Somlyo AP, Gonias SL: Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J Biol Chem 2002;277:12479-12485.
51. Wodarz A: Tumor suppressors: linking cell polarity and growth control. Curr Biol 2000;10:R624-R626.
52. Liu H, Radisky DC, Wang F, Bissell MJ: Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 2004;164:603-612.
53. Chung CY, Potikyan G, Firtel RA: Control of cell polarity and chemotaxis by Akt/PKB and PI3 kinase through the regulation of PAKa. Mol Cell 2001;7:937-947.
54. Waite KA, Eng C: Protean PTEN: form and function. Am J Hum Genet 2002;70:829-844.
55. Itoh N, Semba S, Ito M, Takeda H, Kawata S, Yamakawa M: Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer 2002;94:3127-3134.
56. Singh AB, Harris RC: Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem 2004;279:3543-3552.